T2 Biosystems, Inc.'s Volatile Stock and Negative Fundamentals Make it a Risky Investment

Fundamental Analysis

T2 Biosystems, Inc. (NASDAQ: TTOO) is a health diagnostics company that develops in-vitro diagnostics tools for laboratories and hospitals. The company's shares have been highly volatile recently with a significant decline of 20.31% on August 17, 2023, to close at $0.45.

The company has a negative Earnings Per Share (EPS) of -$8.18, indicating a loss per share for the existing outstanding shares. The company's negative price to earnings (PE) ratio is -0.06, which may be concerning to investors as a negative PE generally suggests that the company is not profitable.

T2 Biosystems, Inc. currently has a market capitalization of approximately $11.28 million with 24.89 million shares outstanding. The average volume of shares traded is 101.42 million, but the volume on the last trading day was higher than usual, at 128.78 million shares, indicating higher investor interest.

Technical Analysis

On a technical front, T2 Biosystems, Inc. has shown a great deal of volatility. The 50-day moving average at $0.15 is significantly lower than the closing price of $0.45, while the 200-day moving average sits at $0.79, considerably higher than the current price. This signifies a downtrend and suggests that, currently, the bearish sentiments within the investors are prevalent.

The Relative Strength Index (RSI14) stands at 70, which is at the threshold of the overbought condition, indicating that the stock may witness a possible reversal or slowdown in the current uptrending price.

T2 Biosystems, Inc.'s move for the past few weeks appears to have been driven by its unexpected popularity among meme stock traders. It had gained as much as 500% in August before the recent drop. However, given the high volatility (ATR at 19.45), any investor must tread with caution.

Outlook and Valuation

Considering the recent news about the company's stock, its popularity appears to be driven by meme stock status rather than fundamentals. The shares slid 20.31% after snapping a three-day winning streak. It shows the highly speculative nature of its recent performance.

For the next trading day, August 18, 2023, considering the significant price drop on the previous trading day, along with the stop loss of $0.43 and negative news sentiment, the stock might struggle to recover and is likely to further declination.

Regarding the next week, it is challenging to predict its position due to the high volatility and uncertainty associated with the current meme-stock trading climate the company finds itself enveloped within.

Final Evaluation

Given T2 Biosystems, Inc.'s high volatility fuelled by its meme stock status, coupled with the potential market overbuying and weak fundamentals reflected by its negative EPS, the stock is risky for conservative investors. Therefore, it could be categorized as a "Sell" for those investors desiring a stable portfolio and capital protection. However, it could be a "Hold" or speculative "Buy" for aggressive traders who can tolerate the high level of risk associated with such volatility in hopes of high returns, although this would be purely speculative and not based on the company's fundamentals. Taking a position in such stocks requires careful risk management and an understanding that any sudden shifts in market sentiment can heavily impact the stock price.